In a pioneering step reflecting the rapid development of the healthcare and logistics sectors in the Kingdom of Saudi Arabia, King Faisal Specialist Hospital and Research Centre announced the launch of an air transport service for short-lived radiopharmaceuticals. This service was inaugurated with a successful pilot flight that transported these vital materials by air from the hospital's main campus in Riyadh to its branch in Jeddah, in close collaboration with relevant authorities in the aviation and logistics sectors.
A race against time to serve cancer patients
This step is of paramount importance due to the physical nature of radiopharmaceuticals; these materials have a very short half-life, meaning their radioactive and medical efficacy declines sharply over time. Previously, geographical challenges and the vast size of the Kingdom hindered the transport of these materials by land without significant loss of efficacy. Air transport offers a solution, ensuring their arrival within the precise timeframe required for clinical use, which directly contributes to improved diagnostic accuracy and enhanced effectiveness of treatment plans for oncology and cancer patients.
Global standards and official licenses
This achievement was not a sudden occurrence, but rather the culmination of diligent efforts that resulted in the hospital obtaining official authorization from the General Authority of Civil Aviation to transport radioactive pharmaceuticals by air. The hospital met all stringent international technical and logistical requirements and standards, ensuring the highest levels of safety and compliance with local and international regulations for handling these highly sensitive materials. This underscores the Kingdom's leading role in implementing nuclear and medical safety standards.
Economic dimensions and sustainable solutions
In addition to its medical benefits, the new service offers a sustainable and cost-effective solution. Instead of investing heavily in complex cyclotron production facilities in each region of the Kingdom, with their associated high-cost equipment and infrastructure, air transport allows the central hub in Riyadh to serve the needs of other branches and hospitals. This approach directs healthcare resources toward more impactful avenues and enhances the quality of nuclear medicine services nationwide.
Continued global leadership
This development reinforces the position of King Faisal Specialist Hospital and Research Centre, which was ranked first in the Middle East and Africa, and 15th globally in the list of the top 250 academic healthcare institutions worldwide for 2025. It is also the most valuable healthcare brand in the Kingdom and the Middle East according to Brand Finance for 2024, reflecting its ongoing commitment to providing the latest medical and logistical solutions to serve the patient.
